Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies

JAMA Psychiatry. 2015 Jul;72(7):731-3. doi: 10.1001/jamapsychiatry.2015.0526.

Authors

Lot D de Witte¹, Carolin Hoffmann², Hans C van Mierlo¹, Maarten J Titulaer³, René S Kahn¹, Pilar Martinez-Martinez²; European Consortium of Autoimmune Mental Disorders (CAIMED)

Collaborators

European Consortium of Autoimmune Mental Disorders (CAIMED):
Mario Losen, Peter Molenaar, Marc De Hert, Christian H Roeder, Nico van Beveren, Bart P F Rutten, Jim van Os, Pilar Martinez-Martinez

Affiliations

¹ Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
² Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht, the Netherlands.
³ Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.

PMID: 25970159
DOI: 10.1001/jamapsychiatry.2015.0526

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / immunology*
Autoantibodies / immunology*
Cohort Studies
Female
Humans
Immunoglobulin G / immunology*
Male
Nerve Tissue Proteins / immunology*
Receptors, N-Methyl-D-Aspartate / immunology*
Reproducibility of Results
Schizophrenia / immunology*
Young Adult

Substances

Autoantibodies
GRIN1 protein, human
Immunoglobulin G
Nerve Tissue Proteins
Receptors, N-Methyl-D-Aspartate